Aspirion Strengthens Revenue Cycle Management with Boost Healthcare Acquisition

Aspirion Expands Revenue Cycle Management Through Boost Healthcare Acquisition



Aspirion, a leader in healthcare technology for revenue cycle management (RCM), has made headlines with its recent acquisition of Boost Healthcare. This strategic move not only strengthens Aspirion's position in the healthcare sector but also enhances its capacity to handle denial management, payment variances, and complex claims. The acquisition signifies a pivotal expansion of Aspirion's mission to ensure healthcare providers receive rightful reimbursements.

Nick Giannasi, CEO of Aspirion, emphasized the significance of finding partners that improve RCM capabilities and deliver increased value to healthcare providers who are currently grappling with financial pressures and complicated reimbursement processes. He stated, “Throughout our growth, we've strategically sought partners who enhance our RCM capabilities and domain expertise, and deliver greater value to healthcare providers.” The acquisition of Boost Healthcare, renowned for its expertise in areas such as zero-balance review and compliance with the No Surprise Act, allows Aspirion to significantly bolster its technological framework and resource capacity.

Jim Bohnsack, Aspirion's Chief Strategy Officer, highlighted that this partnership will broaden Aspirion's offerings to healthcare providers. He remarked, “This strategic union further expands our suite of RCM services for the provider market. By combining our resources, Aspirion will deliver next-generation technology to ensure our provider clients are being paid appropriately for the services they render.” This integration not only aims to identify payment variances both prospectively and retrospectively, but also enables healthcare providers to focus on what they do best: delivering care to communities.

Liana Hamilton, Founder and Managing Partner of Boost Healthcare, expressed her enthusiasm for joining forces with Aspirion. She noted, “Joining the Aspirion family marks an exciting new chapter for Boost Healthcare. Our shared commitment to innovation and client success makes this partnership particularly powerful.” The merger promises to amplify Boost's capabilities with Aspirion’s advanced technology, ensuring that healthcare providers remain financially stable while effectively meeting their patients’ needs.

Aspirion's commitment to innovation in technology has positioned it as a trailblazer in the revenue cycle management sector. With a remarkable track record of client retention, expanding services, and forming new partnerships, Aspirion continues to lead by offering ground-breaking RCM solutions. This acquisition marks a noteworthy milestone, being Aspirion's seventh major acquisition in just six years.

About Aspirion


Aspirion is a U.S.-based company specializing in revenue cycle management that collaborates with healthcare providers to recover difficult claims. Their approach integrates domain expertise, proprietary technology, and artificial intelligence (AI) to recover lost revenue effectively by addressing denials and underpayments, as well as managing complex claims across various sectors such as workers' compensation and Medicaid. The experienced team at Aspirion, consisting of healthcare, legal, and technical professionals utilizes industry-leading technology combined with AI platforms, ensuring healthcare providers receive their deserved revenue so they can concentrate on patient care. Aspirion boasts a diverse clientele across the United States, including approximately half of the nation’s ten largest health systems. To discover more about their services, visit www.aspirion.com.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.